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Abstract
Mycobacterium tuberculosis modulates levels and activity of key intracellular second messengers to evade protective
immune responses. Calcium release from voltage gated calcium channels (VGCC) regulates immune responses to
pathogens. In this study, we investigated the roles of VGCC in regulating protective immunity to mycobacteria in vitro and
in vivo. Inhibiting L-type or R-type VGCC in dendritic cells (DCs) either using antibodies or by siRNA increased calcium influx
in an inositol 1,4,5-phosphate and calcium release calcium activated channel dependent mechanism that resulted in
increased expression of genes favoring pro-inflammatory responses. Further, VGCC-blocked DCs activated T cells that in
turn mediated killing of M. tuberculosis inside macrophages. Likewise, inhibiting VGCC in infected macrophages and PBMCs
induced calcium influx, upregulated the expression of pro-inflammatory genes and resulted in enhanced killing of
intracellular M. tuberculosis. Importantly, compared to healthy controls, PBMCs of tuberculosis patients expressed higher
levels of both VGCC, which were significantly reduced following chemotherapy. Finally, blocking VGCC in vivo in M.
tuberculosis infected mice using specific antibodies increased intracellular calcium and significantly reduced bacterial loads.
These results indicate that L-type and R-type VGCC play a negative role in M. tuberculosis infection by regulating calcium
mobilization in cells that determine protective immunity.
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Introduction
Mycobacterium tuberculosis5 (M. tuberculosis) mediated mortality and
morbidity continue to rise with the emergence of extremely-drug
resistant bacteria, co-infection with HIV and variable efficacy of
protection offered by M. bovis Bacillus Calmette-Guerin (BCG)
vaccine [1,2]. Therefore, there is a need to elucidate factors that
regulate protective immune responses against this pathogen and to
identify targets for development of new drugs [3]. Macrophages,
dendritic cells (DCs) and T cells are instrumental in mediating
immunity to mycobacteria [4–7]. Though, macrophages serve as
long-term hosts for M. tuberculosis [4,5], M. tuberculosis, DCs are also
infected by M. tuberculosis and are crucial to initiate protective
immune responses [8].
Calcium is a universal and important ion that plays an
obligatory role in the regulation of a number of cellular processes.
Calcium concentrations and oscillations govern the selective
activation and inactivation of transcription factors [9]. In most
cells, a typical calcium response occurs in two phases [10]. The
initial response is the depletion of intracellular stores from the
endoplasmic reticulum (ER). This is followed by the activation of
store operated calcium channels that leads to a sustained increase
in intracellular calcium concentrations [11]. This second phase of
calcium influx is either via calcium release calcium activated
(CRAC) channels or via Voltage Gated Calcium Channels
(VGCC) or both [12]. The VGCC consist of a transmembrane
alpha subunit along with a cytoplasmic beta subunit that mediates
signal transduction, with the gamma and delta subunits complet-
ing the core complex [13]. Several intracellular proteins and
adaptors show close associations with VGCC subunits and
regulate various cellular processes [14].
Calcium plays a determinant role in the generation of pro-
inflammatory responses [15] and also regulates the survival of
mycobacteria in macrophages. Calcium dependent phagosome
maturation involves mycobacterial inhibition of sphingosine kinase
that directly contributes to survival of M. tuberculosis within human
macrophages [16]. In addition, tuberculosis toxin has been shown
to inhibit phagosome maturation that involves the calmodulin-
PI3K hVPS34 cascade [17]. Further, L-type VGCC has been
shown to play major roles in regulating calcium homeostasis in
lysosomal storage disease [18] and in Legionella pneumophila infection
[19].
We had earlier shown that several M. tuberculosis antigens
including culture filtrate protein (CFP)-10 (also known as MTSA-
10) induce the differentiation and maturation of DCs [reviewed in
20],[21]. CFP-10 differentiated DCs (CFP10-DCs) are phenotyp-
ically and morphologically similar to DCs differentiated conven-
tionally with GM-CSF [20]. However, functional characterization
showed that, unlike GM-CSF-DCs that induce pro-inflammatory
responses, CFP10-DCs induce suppressor responses [22]. Further,
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CFP10-DCs mount poor oxidative burst that results in increased
bacterial burden [23]. Supplementing calcium results in increased
oxidative burst and reduces bacterial loads. In addition, we
recently showed that mycobacteria infected CFP10-DCs show
reduced secretion of pro-inflammatory chemokines and cytokines.
Conditioning CFP10-DCs with either RANTES & IP-10 or with
IL-12 & IFN-c results in increased mobilization of intracellular
calcium and the induction of pro-inflammatory responses [24].
This in turn leads to increased clearance of established M.
tuberculosis infection in mice which was better than that observed
with drug treatment.
Since calcium played an important role in our experiments and
as the role of VGCC in mediating calcium mobilization during M.
tuberculosis infection has not been investigated in detail, we
therefore, investigated the roles of L-type and R-type VGCC
during M. tuberculosis infection. Since CFP10-DCs and GM-CSF-
DCs share phenotypic similarities [21]) but differed in their
functional outcomes [22,23], we carried out parallel experiments
with both DCs. This approach not only brings out mechanistic
differences between the two DCs but also highlights the functional
relevance of DC differentiation by M. tuberculosis antigens such as
CFP-10. Our data show that inhibiting L-type and R-type VGCC
in DCs, macrophages and PBMCs increases calcium influx. This
results in enhanced expression of pro-inflammatory genes that play
critical roles in protective immunity. Importantly, blocking L-type
and R-type VGCC in macrophages and PBMCs results in reduced
burden of virulent M. tuberculosis, blocking L-type and R-type
VGCC in DCs, activates T cells that mediate killing of M.
tuberculosis inside macrophages. PBMCs of patients with active TB
disease express high levels of the two VGCC. Significantly,
injecting antibodies to L-type and R-type VGCC in mice carrying
an established M. tuberculosis infection results in reduced bacterial
burden. Together, our results suggest a positive correlation of the
expression levels of these VGCC with severity of TB disease and
indicate that L-type and R-type VGCC could be potential
therapeutic targets for treating tuberculosis.
Results
Inhibiting L-type and R-type VGCC in DCs increases
calcium influx
As mycobacteria induced calcium influx was superior in GM-
CSF-DCs than in CFP10-DCs [23,24], to begin with looked at the
roles of L-type and R-type VGCC to investigate their role in
calcium mobilization and the effects thereof on immunity to and
survival of mycobacteria. Although biopharmacological inhibitors
to L-type and R-type VGCC are available [25], in our hands these
inhibitors were toxic to cells even at 0.56IC50 concentrations and
hence could not be used. Therefore, we used specific antibodies to
L-type and R-type VGCC in our experiments. At the onset, we
ensured that the above antibodies showed binding to DCs by
FACS (Figure S1). Our results clearly show that antibodies to both
L-type (panels a and d) and R-type VGCC (panels b and e) showed
binding to VGCC on CFP10-DCs (panels a–c) and GM-CSF-DCs
(panels d–f), while incubation with non-specific antibody (panels c
and f) showed insignificant binding. We next analyzed the effect of
incubation of DCs with these antibodies on calcium influx upon
BCG stimulation. As shown in Figure 1A, stimulation of GM-
Figure 1. Neutralizing L-type and R-type VGCC in DCs induces calcium influx. Real time increase in calcium influx over 5 min in DCs
stimulated with 1 MOI BCG. A, GM-CSF-DCs (a–d) or CFP10-DCs (e–h). Prior to stimulation, DCs were blocked with- anti-L-type antibody (c & g) or anti-
R-type antibody (d & h) or non-specific antibody (b & f). B, calcium influx in BCG stimulated GM-CSF-DCs (a–d) and CFP10-DCs (e–h) following siRNA
mediated silencing of L-type (c & g), R-type (d & h). siRNA against firefly luciferase was used as non-specific control (b & f). Data are representative of
three to five independent experiments.
doi:10.1371/journal.pone.0005305.g001
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CSF-DCs (panel a) resulted in a robust (164 mM) influx of calcium,
while stimulation of CFP10-DCs (panel e) induced weak (78 mM)
calcium mobilization. Surprisingly, incubation with either L-type
(panel c & g) or R-type (panel d & h) VGCC resulted in a
significant increase in calcium influx in both GM-CSF-DCs (536
and 598 mM). A similar increase in calcium influx was observed in
CFP10-DCs (240 and 259 mM). Incubation with a non-specific
antibody (panel b & f) had no significant effect. In addition,
incubation with anti-L-type or anti-R-type antibody had no effect
on calcium levels in uninfected cells (data not shown). Similar
results were obtained when DCs were stimulated with M.
tuberculosis H37Rv whole cell lysate instead of BCG indicating
that the increase in calcium obtained upon blocking L-type and R-
type VGCC was not related to the virulence of the strain (data not
shown). It has been shown CFP-10 forms a dimer with another M.
tuberculosis specific antigen, Early Secreted Antigenic target of
6 kDa (ESAT6) [26]. We therefore, differentiated DCs with
CFP10:ESAT6 dimer and observed that similar to CFP10-DCs,
blocking L-type and R-type VGCC in DCs differentiated with
CFP-10:ESAT6 dimer also increased calcium influx (data not
shown).
In order to see if incubation with antibodies resulted in either
blocking or stimulation of VGCC, we did a similar experiment
employing siRNAs against L-type and R-type VGCC. Figure S2
shows that siRNA treatment indeed decreased the mRNA levels of
L-type and R-type VGCC in CFP10-DCs and GM-CSF-DCs
while treatment with non-specific siRNA had no significant effect
with respect to the respective controls. Next, as shown in Figure 1B,
inhibiting L-type (panels c and g) or R-type (panels d and h)
VGCC with specific siRNA resulted in a similar increase in
calcium mobilization, while non-specific siRNA had no effect
(panels b and f). This indicated that the observed effects with
antibody incubation were a result of blocking of the VGCC. This
further indicated that L-type and R-type VGCC play an inhibitory
role in mobilizing calcium influx in DCs.
We also looked at calcium influx using live cell imaging by time-
lapse confocal video-microscopy. However, over here, experiments
were conducted with M. tuberculosis whole cell lysate (WCL) instead
of live mycobacteria. Our previous results have demonstrated that
CFP10-DCs induce similar responses to M. tuberculosis WCL and
live mycobacteria [23]. Stimulation of CFP10-DCs with M.
tuberculosis WCL induced a weak increase in calcium influx in the
cells (Movie S1). Blocking L-type (Movie S2) or R-type (Movie S3)
VGCC increased calcium influx as seen from increased fluores-
cence of a number of cells and appearance of new fluorescing cells.
Similar results were obtained with GM-CSF-DCs (data not
shown). Figure S3 graphically represents the data obtained by
video microscopy. Blocking L-type (red line) or R-type (green line)
VGCC in CFP10-DCs induced a significant increase in calcium
influx upon M. tuberculosis WCL stimulation.
CFP10-DCs express higher levels of L-type and R-type
VGCC
Since blocking L-type and R-type VGCC increased calcium
influx in both GM-CSF-DCs and CFP10-DCs, we investigated
whether the differential calcium mobilization observed in CFP10-
DCs and GM-CSF-DCs was a result of differential expression of
L-type and R-type VGCC in the two DCs. The binding data in
Figure S1 indicated that uninfected CFP10-DCs expressed higher
surface levels of both L-type and R-type VGCC when compared
with uninfected GM-CSF-DCs. This was also reflected in the
transcript levels of the two DCs (Figure S2). We extended these
observations by looking at their levels following infection of DCs
with BCG. As shown in Figure 2A, both L-type (panel a) and
R-type (panel b) VGCC levels in BCG infected CFP10-DCs were
significantly higher when compared with BCG infected GM-CSF-
DCs. We further confirmed this by looking at their transcript levels
by qPCR. As shown in Figure 2B, BCG infected CFP10-DCs
expressed significantly higher levels of L-type and R-type VGCC
mRNA (P,0.04 and P,0.05, respectively), when compared with
BCG infected GM-CSF-DCs. These results indicated that poor
calcium influx in CFP10-DCs in response to mycobacterial
stimulation could be a result of increased expression of L-type
and R-type VGCC.
Blocking VGCC results in increased release of calcium
from intracellular stores
Intriguingly, since blocking calcium-inducing channels (L-type
and R-type) resulted in further increasing calcium influx, it was
important to identify the source of this calcium. To this end, we
suspended L-type and R-type VGCC-blocked-CFP10-DCs in
calcium sufficient (culture medium) or calcium deficient medium
(PBS) and measured calcium influx upon BCG stimulation. As
shown, under calcium sufficient conditions, both phases of calcium
influx, i.e. the intracellular release followed by import from the
extracellular medium (as a result of activation of CRAC channels
following depletion of intracellular stores [11,12]), could be
observed (Figure 3, panels b and c). In contrast, in calcium
deficient medium, i.e. in the absence of extracellular calcium, one
could only observe increased release of calcium from intracellular
stores (Figure 3, panels e and f). The subsequent phase of calcium
influx from the extracellular medium was not observed. This
indicated that blocking L-type and R-type VGCC resulted in
increased release of calcium from intracellular stores followed by
activation of CRAC channels that together resulted in higher
mobilization of calcium in CFP10-DCs. This was further
confirmed when the release from intracellular stores was inhibited
using TMB-8, wherein the observed increase of both phases was
blocked (Figure 3, panels h and i). One of the intracellular enzymes
involved in the generation of IP3 is Phospholipase Cc (PLCc)
[11,12]. PLCc acts on phosphoinositol 2 phosphate and converts it
into IP3 and diacylglycerol. While IP3 binds to IP3 receptors on
the endoplasmic reticulum to release calcium from intracellular
stores, diacylglycerol activates protein kinase C. We therefore,
specifically blocked PLCc using a biopharmacological inhibitor
and looked at calcium induction following blocking VGCC and
BCG stimulation. As shown in Figure S4, inhibiting PLCc
completely blocked increase in calcium influx upon blocking
VGCC (panels b and c). Put together, the above results clearly
indicate the role of PLCc in calcium induction following blocking
L-type and R-type VGCC.
Blocking L-type and R-type VGCC in DCs increases
expression of Th1 promoting genes
Next, we investigated modulation in the expression of genes in
DCs following blocking of L-type and R-type VGCC. To this end
CFP10-DCs and GM-CSF-DCs were incubated with antibodies to
L-type and R-type VGCC and subsequently infected with BCG.
RNA was enriched, processed and probed against a pathway
specific Th1/Th2/Th3 array. As shown in Figure 4, blocking L-
type and/or R-type VGCC in BCG-infected CFP10-DCs (lower
panels) induced the expression of genes promoting Th1 and pro-
inflammatory responses. This included Fosl1 (spot # B4), CD80
(spot B3), CD86 (spot C3), CCAAT/enhancer binding protein (C/
EBP) beta (Spot # D3), Fosl2 (spot # C4), IL-12p40 (spot # F5),
IL-15 (spot # C6), IL-18 (spot # D6), IL-6 (spot # G7), Jak1 (spot
# E8), NF-kB1 (spot # F10), TNF (spot # D13). Increase in the
Ca Channels and Mycobacteria
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levels of CD80 and CD86 upon L-type and R-type VGCC
blocking indicated that these DCs would be better equipped to
prime T cells. In addition message levels of IL-10 (spot # E5) were
also upregulated. However, increased IL-10 protein levels were
not observed in these groups (data not shown), indicating
regulation at the post-transcriptional level. An essentially similar
pattern was observed in BCG infected GM-CSF-DCs (upper
panels) following blocking of VGCC. The expression of SOCS1
(spot # B11) and SOC3 (spot # D11) were also increased in
addition to IL-10 (spot # E5). Like CFP10-DCs, BCG infected
GM-CSF-DCs did not show increased IL-10 protein levels (data
not shown). These results indicate that high expression of L-type
and R-type VGCC in CFP10-DCs conditioned DCs to induce
suppressor responses via attenuated calcium influx.
Blocking L-type and R-type VGCC induces high IL-12
expression
Although a number of genes were upregulated following VGCC
blocking, we chose to functionally validate two key genes, namely,
IL-12p40 and NF-kB. This was because IL-12p40 plays a
dominant role in regulating pro-inflammatory responses from
DCs that are crucial for mediating protection against M. tuberculosis
infection [6,7]. On the other hand, NF-kB positively regulates the
expression of many genes that were upregulated including TNF,
IL-15 and IL-18 [27]. As shown in Figure S5, compared to
GM-CSF-DCs, CFP10-DCs showed reduced activation of NF-kB
as ascertained by EMSA (P,0.009). Supershift analyses showed
that the bound complex consisted of c-Rel and p65 subunits (data
not shown). However, blocking L-type and R-type VGCC in
CFP10-DCs (and also in GM-CSF-DCs) resulted in increased
activation of NF-kB. The increase in the activation was more
evident with R-type blocking when compared with L-type
blocking.
We next investigated whether blocking L-type and R-type
VGCC results in increased expression of IL-12p40. To this end,
we monitored the acetylation of histone H3 at the IL-12p40
promoter between position 2121 to 2131 (a region that has been
functionally characterized to be important for IL-12 expression)
[28], by chromatin immunoprecipitation (ChIP) and protein
expression by ELISA. As shown in Figure 5A, ChIP analyses
showed increased pull down of acetylated histone H3 in BCG
infected GM-CSF-DCs when compared with CFP10-DCs, as
evident by increased levels of the PCR amplified product. In fact,
IL-12p40 levels in BCG infected CFP10-DCs were lower than
uninfected DCs, thus confirming our earlier observations [23] at
the transcriptional level. Specificity of ChIP was ascertained
when no amplification was obtained in the group where the
antibody against histone H3 was omitted. This indicated
increased transcriptional activity at the IL-12p40 promoter in
GM-CSF-DCs. However, blocking L-type and R-type VGCC in
Figure 2. CFP10-DCs express higher levels of L-type and R-type VGCC following BCG infection. Histograms in Panel A show surface levels
of L-type (panel a) and R-type (panel b) in BCG infected CFP10-DCs (thick lines) and BCG infected GM-CSF-DCs (thin lines). Panel B shows, results from
qPCR of L-type and R-type VGCC transcripts in BCG infected DCs. The Bars represent 22DDCT values in BCG infected CFP10-DCs and GM-CSF-DCs. Data
are the mean of three independent experiments. Error bars represent mean6S.D. P,0.008 (for L-type levels between CFP10-DCs and GM-CSF-DCs);
P,0.02 (for R-type levels between CFP10-DCs and GM-CSF-DCs). Two-tailed Student’s t-test was employed for P values.
doi:10.1371/journal.pone.0005305.g002
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CFP10-DCs showed increased pull down of acetylated histone
H3 resulting in increased levels of the PCR product. This
indicated a direct role of blocking L-type and R-type VGCC in
mediating increased IL-12p40 transcriptional activity. The
reduced levels of PCR product in GM-CSF-DCs in the presence
of L-type and R-type VGCC blocking could be a result of
feedback regulation, since the levels were quite high upon BCG
infection itself. The ChIP data corroborated very well with the
protein levels of IL-12p40. Blocking L-type and R-type VGCC in
BCG infected CFP10-DCs (Figure 5B) significantly increased IL-
12p40 levels.
T cells activated by VGCC-blocked-DCs mediate killing of
M. tuberculosis in macrophages
To investigate the functional relevance of the results obtained so
far, we next tested the ability of T cells activated by VGCC-blocked
DCs to kill mycobacteria inside macrophages as recently carried out
with chemokine and cytokines conditioned CFP10-DCs [24]. We
first ensured that blocking L-type and R-type VGCC in CFP10-
DCs and GM-CSF-DCs activated T cells that secreted high levels of
IFN-c and low levels of IL-10 (data not shown). Next, BCG infected
DCs were co-cultured with T cells enriched from BCG immunized
mice. Form the DC-T cell co-culture, T cells were separated by
MACS and incubated with M. tuberculosis H37Rv infected
macrophages. Control groups included M. tuberculosis infection of
resting and IFN-c activated macrophages in the absence of any T
cell addition. CFU in macrophages incubated with T cells that were
activated by L-type and R-type VGCC-blocked-BCG-infected
CFP10-DCs, showed a significant decrease when compared to
CFU from either M. tuberculosis infected resting or activated
macrophages or when compared with T cells activated by
CFP10-DCs in the absence of VGCC blocking (Figure 6). A similar
decrease in CFU were seen when T cells activated by L-type and R-
type VGCC-blocked-BCG-infected GM-CSF-DCs were employed.
These results indicate that blocking L-type and R-type VGCC in
DCs activated T cells that subsequently mediated effective killing of
virulent M. tuberculosis inside macrophages.
Blocking L-type and R-type VGCC in macrophages and
PBMCs kills M. tuberculosis
Next it was relevant to investigate whether blocking L-type and
R-type VGCC in mouse macrophages or human PBMCs would
mediate effective killing of M. tuberculosis. We first monitored
whether blocking L-type and R-type VGCC induced calcium
influx in macrophages and PBMCs. BCG stimulation of
macrophages (Figure 7A) or PBMCs (Figure 7B) did not induce
appreciable levels of calcium influx (28.7 mM and 39.4 mM,
respectively). However, blocking either L-type or R-type VGCC
induced a significant increase in calcium mobilization in both
macrophages (54.9 mM and 53.7 mM, respectively) and PBMCs
Figure 3. Blocking VGCC increases calcium release from intracellular stores. Real time increase in calcium influx over 5 min in CFP10-DCs
stimulated with 1 MOI BCG. Prior to stimulation, DCs were blocked with anti-L-type antibody (b, e & h) or anti-R-type antibody (c, f, & i). Subpanels a, d
and g represent BCG stimulation in the absence of VGCC blocking. For panels A and B, DCs were suspended in calcium sufficient (RPMI) medium and
calcium (PBS) deficient medium, respectively. For panel C, DCs were incubated with 100 mM TMB-8 prior to blocking with L-type or R-type VGCC and
calcium measurements were carried out in calcium sufficient (RPMI) medium. Data from one of three independent experiments are shown.
doi:10.1371/journal.pone.0005305.g003
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(169.2 mM and 196.5 mM, respectively). This indicated that
L-type and R-type VGCC played an inhibitory role in calcium
mobilization even in these cells. The increase was more evident in
the case of PBMCs when compared with macrophages.
Next, mouse macrophages or human PBMCs were infected
with M. tuberculosis H37Rv for 24 h. Cells were then incubated
with antibodies to L-type and R-type VGCC and cultured for
48 h. Subsequently, cells were lysed and monitored for CFU. As
shown in Figure 7C, blocking L-type and R-type VGCC in either
mouse macrophages (left panel) or human PBMCs (right panel)
resulted in effective killing of M. tuberculosis. In fact the reduction
was 2-fold better than that observed with IFN-c activated
macrophages or PBMCs. Similar results were obtained upon
inhibition of VGCC using specific siRNAs (Figure S6). These
results indicated that L-type and R-type VGCC prevent calcium
responses in macrophages and PBMCs resulting in defective
clearance of M. tuberculosis.
PBMCs of patients with active TB disease express high
levels of L-type and R-type VGCC
In order to give physiological relevance to the data obtained
thus far, we looked at the levels of L-type and R-type VGCC in
human cohorts of healthy controls (n = 6), patients with active TB
(n = 11) and patients undergoing chemotherapy (n = 11). Five
patients consented to be bled again at two months post-therapy,
while six patients who had already received two months of therapy
consented to give blood for the study. Figure 8 shows data from
the five patients who consented to give blood at the time of
diagnosis and following two months of therapy along with three
healthy controls. Compared with healthy controls, PBMCs of
patients with active TB disease expressed high levels of both L-type
(P,0.05) and R-type (P,0.07) VGCC. Interestingly, PBMCs of
the same patients following 2 months of chemotherapy, wherein
their sputum became AFB2, now displayed highly reduced levels
of L-type (P,0.05) and R-type VGCC (P,0.08). In fact the levels
Figure 4. Blocking L-type and R-type VGCC in DCs induce expression of Th1 promoting genes. Expression levels of Th1/Th2/Th3 pathway
specific gene array in GM-CSF-DCs (upper panels) or CFP10-DCs (lower panels) infected with 1 MOI BCG for 24 h in the presence or absence of anti-L-
type or anti-R-type antibody blocking. Spot # A1, GAPDH control; spot # C15, # D15 and # E15 are negative controls. Data from one of two
independent experiments are shown.
doi:10.1371/journal.pone.0005305.g004
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were very similar to or in some cases even lower than healthy
controls. Similar results were obtained in the other 6 patients with
active disease and patients who had taken 2 months of therapy,
wherein PBMCs of patients with active TB expressed higher levels
of L-type and R-type VGCC when compared with patients who
had taken treatment (data not shown). These results are consistent
with the data obtained in Figure 7, wherein blocking L-type and
R-type VGCC in macrophages and PBMCs resulted in reduced
bacterial loads.
Blocking VGCC in vivo reduces bacterial burden in mice
In order to test proof of principle, we next investigated the role
of L-type and R-type VGCC in regulating M. tuberculosis infection
in mice. To this end, we first infected mice with M. tuberculosis
H37Rv. Post-exposure we followed it up by injection of antibodies
to VGCC. We first investigated whether antibody treatment would
indeed increase intracellular calcium in vivo. As shown in
Figure 9A, splenocytes from M. tuberculosis infected mice showed
higher calcium levels when compared to splenocytes from
uninfected mice. However, following anti-L-type and anti-R-type
VGCC antibody injection in infected mice, intracellular calcium
levels in splenocytes were significantly higher when compared
either in the absence of antibody treatment or following injection
of a non-specific antibody. This indicated that injection of
antibodies to VGCC elevates intracellular calcium concentrations
in cells in vivo during M. tuberculosis infection. In the next
experiment, mice were infected with M. tuberculosis H37Rv and
seven days later mice were injected with antibodies to L-type and
R-type VGCC and bacterial loads in lungs and spleen were
determined seven days following injection of antibodies. As shown
in Figure 9B, CFU counts in lungs were reduced by 50% in mice
that received antibodies to L-type and R-type VGCC when
compared with mice that received a non-specific antibody
(P,0.006) or control (P,0.001). Similarly, the CFU in spleen
Figure 5. Blocking L-type and R-type VGCC induces high
expression of IL-12p40. A, ChIP analysis of acetylated histone H3
(AcH3) from the IL-12p40 promoter in uninfected (U) or BCG infected
CFP10-DCs or GM-CSF-DCs in the presence or absence of anti-L-type (L)
or anti-R-type (R) antibody. Nab, no antibody in BCG infected GM-CSF-
DCs. Data from one of three independent experiments are shown. B, IL-
12p40 levels in culture supernatants of CFP10-DCs processed as in A.
Data from one of three independent experiments are shown.
doi:10.1371/journal.pone.0005305.g005
Figure 6. T cells activated by L-type and R-type VGCC-blocked-DCs kill M. tuberculosis inside macrophages. L-type or R-type VGCC-
blocked-BCG-infected GM-CSF-DCs (GMCSF) or CFP10-DCs (CFP10) were co-cultured with T cells from BCG immunized mice. From the co-culture, T
cells were enriched and incubated with M. tuberculosis H37Rv infected macrophages. Cells were lysed and CFU was determined. As controls, infected
macrophages without incubation with T cells and macrophages treated with 2 ng/ml IFN-c prior to infection with M. tuberculosis in the absence of T
cell addition were also included. Data are the mean of three independent experiments. Error bars represent mean6s.d. P,0.01 for Mph+IFN-g vs
CFP10+anti-Ltype; P,0.01 for Mph+IFN-g vs CFP10+anti-Rype and P,0.006 for Mph vs GMCSF+anti-Ltype. Two-tailed Student’s t-test was employed
for P values.
doi:10.1371/journal.pone.0005305.g006
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Figure 7. Blocking L-type and R-type VGCC in macrophages and PBMCs increases calcium influx and kills intracellular M.
tuberculosis. Real time increase in intracellular calcium over 5 min following stimulation of mouse macrophages (A) or human PBMCs (B) with 1 MOI
BCG. Subpanel a- BCG stimulation, b & c anti-L-type and anti-R-type antibody blocking prior to BCG stimulation. C, M. tuberculosis H37Rv CFU in
macrophages (left panel) or PBMCs (right panel) in the presence or absence of anti-L-type and anti-R-type antibody. IFN-g, cells incubated with 2 ng/
ml IFN-c prior to infection with M. tuberculosis H37Rv. Data are the mean of three independent experiments. Error bars represent mean6s.d. In C left
panel P,0.09 for Mph+IFN-g vs Mph+anti-Ltype+anti-Rtype, P,0.005 for Mph vs Mph+anti-Ltype+anti-Rtype; right panel P,0.03 for PBMCs vs
PBMCs+anti-Ltype+anti-Rtype, P,0.09 for PBMCs+IFN-g vs PBMCs+anti-Ltype+anti-Rtype. Two-tailed Student’s t-test was employed for P values.
doi:10.1371/journal.pone.0005305.g007
Figure 8. Patients with active TB disease display higher levels of L-type and R-type VGCC. RT-PCR of L-type and R-type VGCC transcripts
in PBMCs from healthy controls, patients with active TB disease and the same patients following 2 months of chemotherapy. b-actin levels are
depicted as loading control. For L-type P,0.053 (for healthy vs patients) and for R-type P,0.08 (for patients vs follow-ups). Two-tailed Student’s t-test
was employed for P values.
doi:10.1371/journal.pone.0005305.g008
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were also reduced by 50% upon injection of VGCC specific
antibodies when compared with mice that received non-specific
antibody (P,0.005). These results indicate that blocking VGCC in
vivo results in reduction of M. tuberculosis infection as a result of
increased calcium influx in infected cells.
Discussion
M. tuberculosis has devised numerous ways to evade protective
immune responses [3–5] by modulation of host factors. These
include downmodulation of surface MHC class II expression on
macrophages and changes in the profile of cytokines and
chemokines in DCs that individually and collectively affect
priming of T cells [5]. Other modulations include downregulation
of reactive nitrogen and reactive oxygen species generation,
inhibition of IFN-c receptor expression and activation on
macrophages [29,30]. A number of immune evasive effects of
M. tuberculosis are reproduced by specific M. tuberculosis antigens.
These include inhibition of IFN-c and Toll Like Receptor
pathways by 19 kDa lipoprotein [31], inhibition of NF-kB
activation and IL-12 production by mannosylated lipoarabinoma-
nan mediated activation of DC-SIGN [32]. On similar lines, we
have also demonstrated the immuno-suppressive effects of CFP-10
that mediates its effects by inducing differentiation of DCs that
confer suppressor responses [21,24].
Calcium plays a key role in regulating many of the modulations
that are targeted by M. tuberculosis for immune evasion. For
example, calcium regulates the activities of calmodulin and
sphingosine kinase that affects M. tuberculosis survival [16]; and
calcinuerin that regulates the expression of coronin-1 on
phagosomes thus affecting phagosome maturation [33]. In
addition, calcium concentrations and kinetics directly affect the
activation of transcription factors such as NF-AT and NF-kB
leading to differential cytokine expression and this governs the
quantum and quality of immune responses [34]. As described
earlier, calcium influx in mammalian cells is stage dependent,
initiating with the depletion of intracellular stores followed by
opening up of various channels [10,11]. Although, VGCC have
been shown to play major roles in physiological responses, their
roles in infectious diseases have recently assumed importance. For
Figure 9. Treatment of mice with anti-L-type and anti-R-type antibodies increases intracellular calcium and reduces M. tuberculosis
burden. A, intracellular calcium levels in splenocytes from mice infected with M. tuberculosis H37Rv (panel b), or mice infected with M. tuberculosis
H37Rv followed by i.v. injection of 25 mg each of anti-L-type and anti-R-type (panel c) or non-specific antibody (panel d). Panel a shows intracellular
calcium in splenocytes from naı¨ve mice that received anti-L-type and anti-R-type antibody in the absence of M. tuberculosis infection. B, Mice were
infected i.v. with M. tuberculosis H37Rv followed by i.v. injection of 25 mg each of anti-L-type and anti-R-type or non-specific antibody 7 d later. Mice
were sacrificed and lungs and spleen homogenates were plated for determining CFU after 7 d following antibody treatment. Control represents M.
tuberculosis H37Rv infected mice treated with PBS. Data are the mean of three independent experiments. Error bars represent mean6s.d. P,0.001 in
lungs for control vs anti-L type+anti-R type, P,0.006 in lungs for non-specific antibody vs anti-L type+anti-R type, P,0.003 in spleen for control vs
anti-Ltype+anti-Rtype, P,0.005 in spleen for non-specific antibody vs anti-L type+anti-R type. Two-tailed Student’s t-test was employed for P values.
doi:10.1371/journal.pone.0005305.g009
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example, L-type VGCC has been demonstrated to play roles in
regulating intracellular growth of Legionella pneumophila [19] and in
induction of calcium in CD4+ T cells during Leishmania infection
[35].
Therefore, in the present study, we investigated the roles of L-
type and R-type VGCC in mediating protective responses during
M. tuberculosis infection. Our results showed that inhibiting or
blocking L-type and R-type VGCC in DCs, macrophages and
human PBMCs increased intracellular calcium concentration
(blocking PQ-type and T-type VGCC completely inhibited even
basal calcium induction and hence were not pursued further; data
not shown). This indicated a negative role for L-type and R-type
VGCC in calcium influx in the context of M. tuberculosis infection.
L-type VGCC has been previously reported to play a negative role
in calcium induction wherein the knockdown of its beta subunit in
mouse results in increased frequency of calcium oscillations
leading to increased insulin secretion in beta cells [36]. In
addition, blocking L-type and R-type VGCC increased the
expression and kinetics of a number of cytokines (in particular
IL-12) and transcription factors that promote pro-inflammatory
responses. Several reports indicate a role for VGCC in regulating
the activation of transcription factors. For example, L-type VGCC
has been shown to be essential for CREB phosphorylation [37]
and activation of c-fos [38].
We next showed that L-type and R-type VGCC directly
affected survival of M. tuberculosis. Blocking L-type and R-type
VGCC in macrophages or PBMCs resulted in killing of M.
tuberculosis. Blocking L-type and R-type VGCC in DCs, primed T
cells that mediated killing of M. tuberculosis inside macrophages.
The fact that M. tuberculosis killing was better than that obtained by
IFN-c treatment indicates that blocking L-type and R-type VGCC
could bypass the suppressive effects of M. tuberculosis on IFN-c
mediated clearance. Blocking VGCC in infected macrophages also
induced increased cleavage of caspase-3 (Figure S7). It has been
shown that M. tuberculosis prevents apoptosis of infected macro-
phages leading to decreased antigen presentation [5]. Calcium also
induces caspase-3 activation [39], thereby indicating a role for L-
type and R-type VGCC blocking in calcium mediated caspase
activation during M. tuberculosis infection. M. tuberculosis has been
shown to interact differently with DCs and macrophages. These
include opposite effects on MHC class II levels, IL-12 and IFN-c
secretion and regulation [30,31,40]. In this study, we have
identified a common factor in the form of L-type and R-type
VGCC that negatively governs protective responses from both
DCs and macrophages that could be targeted for therapeutic
intervention.
It is pertinent to mention here that the role of VGCC in DCs
has been a subject of contention. While some report the presence
of active VGCC in DCs [41], others observed that calcium influx
is mainly via CRAC channels [42]. Our data indicate that these
channels play a direct role in generation of immune responses
from DCs and macrophages. The role of L-type VGCC in CD4+
T cells has recently been shown in the context of Leishmania
infection wherein despite being non-excitable, these T cells express
functional L-type VGCC [35]. VGCC in these T cells play a
major role in inducing calcium influx with their association with
the scaffold protein AHNAK-1 [35]. Therefore, the data on T cells
add support to our results, wherein these channels directly
influence functional outcomes in non-excitable cells.
The negative role of L-type and R-type VGCC during M.
tuberculosis infection was further established with our in vivo data,
wherein blocking VGCC in M. tuberculosis infected mice signifi-
cantly reduced bacterial loads in infected mice. The in vivo data
correlated well with our results in human cohorts, wherein high
expression of L-type and R-type VGCC was observed in patients
with active TB disease when compared with healthy controls.
Following chemotherapy, the levels of these VGCC decreased
significantly. Furthermore, blocking VGCC in PBMCs of healthy
or TB patient increased the expression levels of granulysin, IFN-c
receptor2 that are known to mediate killing of M. tuberculosis and
also downregulated the expression of genes such as CCL2 that
promotes Th2 responses (data not shown) pointing to possible
downstream mechanisms that would together bring about a
reduction in M. tuberculosis burden in infected cells. Interestingly,
blocking these VGCC inhibited invasion of erythrocytes by
Plasmodium falciparum and this indicated that these channels play
a role during infections by other pathogens (data not shown).
Collectively, our results suggest that L-type and R-type VGCC
play important roles in regulating immune responses during M.
tuberculosis infection. Inhibition of these channels results in
significant increase in calcium mobilization leading to expression
of pro-inflammatory genes and the generation of protective
immunity to mycobacteria. Significantly, our results on patient
samples further indicate that these channels are expressed at high
levels during active disease, indicating a negative role played by
these VGCC during M. tuberculosis infection. Finally, the reduction
of M. tuberculosis infection in mice treated with antibodies to L-type
and R-type VGCC indicates their potent roles in determining the
course of infection during different stages of M. tuberculosis infection
and TB disease.
Materials and Methods
Animals
Female BALB/c mice 4–6 wk of age kept in pathogen free
environment and all experiments were conduced following
approval from the ICGEB animal ethics committee.
Human Studies
All experiments were conducted following approval by the
human ethics committee of LRS Institute of TB & Respiratory
diseases. Following written informed consent venous blood from
PPD+ healthy volunteers or patients in the age group of 15–60
years freshly diagnosed with active TB (based on acid fast bacilli
(AFB)+ sputum smear, chest X-Ray and clinical examination) was
drawn and PBMCs were enriched. None of the healthy volunteers
or patients had any previous record of TB or anti-tuberculosis
treatment. Further, either HIV+ or immuno-compromised or
pregnant women were excluded from the study.
Materials
Antibodies to L-type Ca2+ a1C (cat # sc-25686) and R-type
Ca2+ a1E (cat # sc-16225) VGCC, NF-kB p65 subunit (cat # sc-
7151), siRNA against L-type Ca2+ CP a1C (cat # sc-42689) and
R-type Ca2+ CP a1E VGCC (cat # 42703) and NF-kB binding
consensus oligonucleotides were purchased from Santa-Cruz
Biotechnologies. ELISA kits for cytokines were purchased from
R&D systems. Acetylated Histone 3 ChIP kits were from Upstate
Biotechnology, Inc. Lake Placid, NY. Defined pathway specific
mouse Th1/Th2/Th3 (cat # OMM-034) along with True
labeling AMPTM 2.0 kits (cat # GA030) were from SuperArray.
Expression and purification of CFP-10
Endotoxin free CFP-10 was recombinantly expressed and
purified as a His-tagged protein from E. coli as described earlier
[21–24]. The endotoxin levels were estimated to be 0.3 EU per mg
protein.
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Enrichment of DC precursors from bone marrow and
generation of DCs
DCs were differentiated with either GM-CSF or CFP-10 as
described before [21–24]. Briefly, bone marrow from the tibias
and femurs of BALB/c mice were flushed out and lymphocytes
and I–A+ cells were depleted following MACS. Cells were cultured
in RPMI 1640 medium containing 10% FCS, 0.05 M 2-
mercaptoethanol, 1 mM sodium pyruvate plus either 15 ng/ml
GM-CSF or 20 mg/ml CFP-10. DCs differentiated with CFP-10
are referred as CFP10-DCs, while DCs differentiated with GM-
CSF are referred as GM-CSF-DCs. We have shown that this
method gives a homogenous population that is 99% DCs with
negligible contaminating monocytes or macrophages [21,23].
Enrichment of macrophages and PBMCs
Mouse peritoneal macrophages were flushed using RPMI 1640
medium using a sterile syringe and an 18 guage needle. The cells
were washed in PBS. Human PBMCs were enriched from
heparinized blood by Ficoll-Histopaque density gradient centrifu-
gation. Cells at the interface were removed and washed in PBS.
Enriched macrophages and PBMCs were cultured in RPMI 1640
medium containing 10% FCS, 0.05 M 2-mercaptoethanol, 1 mM
sodium pyruvate.
Infection of cells with M. bovis BCG and M. tuberculosis
H37Rv
M. bovis BCG and M. tuberculosis H37Rv were grown in
Middlebrook 7H9 liquid medium supplemented with albumin/
dextrose/catalase (ADC) at a final concentration of 5 g/l, 2 g/l
and 0.003 g/l, respectively, along with 0.05% Tween 80. Aliquots
were frozen at 285uC and viable bacteria were enumerated by
plating serial dilutions on 7H11 agar. DCs were infected with
BCG, while mouse peritoneal macrophages and human PBMCs
were infected with M. tuberculosis H37Rv at 1 MOI for different
times. Cells were processed either for measuring intracellular
calcium influx or co-cultured with T cells or for monitoring colony
forming unit (CFU) as described below.
Binding of antibodies to L-type and R-type VGCC to DCs
Antibodies to L-type Ca2+ a1C and R-type Ca2+ a1E VGCC
and NF-kB p65 subunit were biotinylated using NHS biotin as per
standard protocols. DCs were incubated with Fc-block (BD
Biosciences) followed by incubation with the above antibodies at
1 mg/106 cells at 4uC for 30 min. Cells were washed and counter
stained with streptavidin-PE. FACS was performed using FACS
Calibur (Beckton & Dickinson) and the data were analyzed
employing the CellQuest Pro software.
Estimation of intracellular calcium levels
Intracellular calcium levels were monitored essentially as
described before [24]. Briefly, either 26107/ml GM-CSF-DCs
or CFP10-DCs or mouse macrophages or human PBMCs were
loaded with 1 mM FLUO-3-AM for 45 min at 37uC in culture
medium. The cells were thoroughly washed with HBSS and
suspended in fresh culture medium. An aliquot of cells was diluted
in culture medium and when required stimulated with 1 MOI
BCG and real time increase in intracellular calcium concentration
was monitored immediately over a period of 5 min by FACS using
FACS Calibur (Beckton & Dickinson) and the data were analyzed
employing the CellQuest Pro software. For some groups, cells
were incubated with 2 mg/ml of L-type or R-type VGCC for
30 min. Alternatively, DCs transfected with siRNA against L-type
or R-type VGCC were used for measuring calcium influx as
described below. For CFP10-DCs and GM-CSF-DCs the voltage
gains were adjusted so as to obtain a similar baseline prior to
stimulation. The gates selected to plot the histograms within
CFP10-DCs and GM-CSF-DCs with different treatments are the
same.For some experiments, mice (4 mice/group) were infected
intravenously with 16106 M. tuberculosis H37Rv for 24 h followed
by intravenous injection of 25 mg each of anti-L-type and anti-R-
type or a non-specific antibody. Splenocytes were excised 4 h later
and loaded with 1 mM FLUO-3-AM for 45 min in culture
medium. Intracellular calcium levels were measured by acquiring
cells for a period of 5 min by FACS as mentioned above. No
stimulations were made during the acquisition. A control group
wherein naı¨ve mice were injected with 25 mg each of anti-L-type
and anti-R-type was also included to see any effect of the antibody
in the absence of M. tuberculosis infection.
Transfection of DCs with siRNA
56106/ml bone marrow precursors were transfected with
60 pmoles of siRNA against L-type and R-type VGCC for 72 h
using the Hiperfect transfection reagent (Qiagen) in OPTIMEM
medium (Invitrogen). 5 h following transfection either GM-CSF or
CFP-10 was added and the incubation continued for 72 h for DC
differentiation. Subsequently, RNA was enriched using TRIZOL
reagent and levels of VGCC were monitored by RT-PCR.
Alternatively, cells were processed for calcium measurements as
described above.
Time-lapse confocal video microscopy
16105 DCs were seeded in RPMI 1640 culture medium
supplemented with 10% FCS in 30 mm glass-bottom micro well
dishes in 150 ml for 14–16 h. DCs were incubated with blocking
antibodies to L-type and R-type VGCC for 1 h and then loaded
with Fluo-3-AM for 45 min at 37uC. The cells were washed two
times with phenol red free RPMI-1640 medium. Confocal live cell
imaging was performed with Nikon TE-2000-E laser-scanning
confocal microscope (Nikon, Japan) with 606 objective magnifi-
cation, numerical aperture 1.4, PlanApo optics, equipped with
Argon laser, using excitation and emission wavelength of 488 and
516, respectively. The images were acquired with a frame rate of
2 seconds for a total duration of 180 s and 90 frames were
recorded. The cells were stimulated with 10 mg/ml M. tuberculosis
whole cell lysate (WCL) at the 15th frame (30 s).
Quantitative and semi-quantitative RT-PCR
Total RNA from cells processed differently was isolated. RNA was
employed in real time quantitative RT-PCR using SYBRgreen on a
Bio-Rad iCycler. The expression level of a gene in a given sample
was represented as 22DDCT, where DDCT = [DCT(sample, infected)] –
[DCT(sample, uninfected)] and DCT = [CT(sample)] – [CT(b-actin)], where
b-actin is the housekeeping gene. Semi-quantitative RT-PCR was
carried out on a Bio-RAD MyCycler. The following primers were
used: for mouse L-type VGCC forward 59 GGCTGGAGGTGA-
CATCGAGGG 39 and reverse 59GAGGCAATGGAGCGCACT-
GAG 39 at 95uC 1 min, 54uC 1 min, 72uC 1 min; for mouse R-type
VGCC forward 59 TCGACAGTGGTGAACATTAGC 39 and
reverse 59 CGCTTGATGGTTTTCAGTGGC 39 at 95uC 1 min,
55uC 1 min, 72uC 1 min; for human L-type VGCC forward 59
AGTCCGTCAACACCGAAAAC 39 and reverse 59 CCAGTTG-
GGCTGGTTGTAGT 39 at 95uC 1 min, 56uC 1 min, 72uC; for
human R-type VGCC forward 59 ATGACGGTCCACTT-
CACCTC 39 and reverse 59 AGAGACTGCCGTTCTTGGAA
39 at 95uC 1 min, 60uC 1 min, 72uC; mouse b-actin forward 59
TGTTACCAACTGGGACGACA 39 and reverse 59 AAG-
GAAGGCTGGAAAAGAGC 39 at 95uC 1 min, 60uC 1 min,
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72uC 1 min; and human b-actin forward 59 AGAAAATCTGG-
CACCACACC 39 and reverse 59 AGGAAGGAAGGCTGGAA-
GAG 39 at 95uC 1 min, 60uC 1 min, 72uC 1 min. The products
were separated on 1% agarose gel and visualized.
Microarray analyses
All steps were conducted strictly following the manufacturer’s
(SuperArray) protocol. DCs were infected with BCG for 24 h in
the presence and absence of blocking antibodies to L-type and R-
type VGCC. Total RNA was enriched and 2 mg RNA was
processed and converted into c-RNA. Following normalization c-
RNA was probed against pathway specific Th1/Th2/Th3 oligo-
GEArrays.
Elecrophoretic Mobility Shift Assays (EMSA)
DCs were infected with 1 MOI BCG for indicated times and
nuclear extracts were prepared as described elsewhere [24].
Briefly, at the end of the incubation cells were chilled on ice and
washed once with ice-cold PBS and lysed in buffer containing
10 mM HEPES (pH 7.9); 10 mM KCl; 0.1 mM EDTA; 0.1 mM
EGTA, 0.5% Nonidet P-40, and 2 mg/ml each of aprotinin,
leupeptin and pepstatin. The suspension was centrifuged at
13,000 rpm for 1 min at 4uC. The nuclear pellet was resuspended
in ice-cold extraction buffer- 20 mM HEPES, pH 7.9; 0.4 M
NaCl; 1 mM EDTA; 1 mM EGTA; 1 mM DTT; 1 mM PMSF
and 2 mg/ml each of aprotinin, leupeptin and pepstatin. EMSA
were performed by incubating 12–15 mg of nuclear extract with
32P-end-labeled 19-mer double stranded consensus NF-kB oligo-
nucleotide sequence for 15 min at 37uC. The incubation mixture
included 2–3 mg of poly(dI.dC) in a binding buffer (25 mM Hepes,
pH 7.9; 0.5 mM EDTA; 0.5 mM DTT; 1% Nonidet P-40; 5%
glycerol; 50 mM NaCl). The DNA-protein complex formed was
separated from free oligonucleotide on 5% native polyacrylamide
gel using buffer containing 50 mM Tris, 200 mM glycine
(pH 8.5), and 1 mM EDTA, and the gel was then dried. The
specificity and extent of binding was examined by competition
with unlabeled (cold) oligonucleotide. For supershift assays,
nuclear extracts were incubated with antibodies against either c-
Rel or p65 subunits of NF-kB for 30 min at room temperature
before the complex was analyzed by EMSA.
Chromatin Immunoprecipitation (ChIP) Assay
The ChIP procedure was carried out following the manufac-
turer’s instructions (Upstate Biotechnology) with some modifica-
tions. Briefly, following specific stimulus, 36106 cells were fixed
with 1% formaldehyde for 10 min at 37uC and quenched with
0.125 M glycine for 10 min at room temperature. Chromatin was
sheared to an average size of ,500 bp and precleared with protein
A-agarose beads. The soluble chromatin was incubated overnight
with 2–3 mg of anti-acetylated histone H3 followed by incubation
with the blocked beads. The immune complexes were collected by
centrifugation and washed following the manufacturer’s protocol.
Input and immunoprecipitated chromatin samples were reverse
cross-linked by incubation at 65uC overnight in presence of
200 nM NaCl. Following proteinase K digestion, DNA was
extracted with phenol/chloroform and precipitated with ethanol.
Precipitated DNA was diluted serially, analyzed by PCR consisting
of 30 amplification cycles, and resolved on agarose gel.
Enrichment of T cells
BALB/c mice were immunized with 16106 BCG subcutane-
ously at base of tail. Seven days later, inguinal lymph nodes were
excised. From this B cells, macrophages and DCs were removed
following MACS using anti-B220+, anti-CD11c+ and anti-CD11b+
microbeads. The negatively selected T cells were 98% pure as
determined by CD90-PE staining. The percentage of I–A+ cells in
T cell preparations was 0.5%.
Intracellular survival of mycobacteria
DCs were infected with 1 MOI BCG for 24 h in the presence
and absence of antibodies to L-type and R-type VGCC as
described above. DCs were then co-cultured for 48 h with BCG-
specific T cells enriched from immunized mice. From this co-
culture DCs were selectively depleted and T cells were cultured for
48 h with M. tuberculosis H37Rv infected macrophages. Cells were
lysed and plated in serial dilutions onto 7H11 agar plates.
Alternatively, mouse peritoneal macrophages or human PBMCs
were infected with 1 MOI M. tuberculosis H37Rv for 24 h. Infected
cells were then washed and incubated with antibodies to L-type
and R-type VGCC for a further 48 h. Cells were lysed and plated
in serial dilutions onto 7H11 agar plates. Two to three week later
plates were scored for Colony Forming Units (CFU).
Infection of mice with M. tuberculosis
Groups of naı¨ve mice (4/group) were infected with 16106 M.
tuberculosis H37Rv via the tail vein. One group of mice was
sacrificed 24 h later and lung homogenates were plated onto 7H11
agar plates for confirming infection. Seven days post infection,
25 mg each of anti-L-type and anti-R-type or a non-specific
antibody was injected into the tail vein of mice. Seven days
following injection, mice were sacrificed and lung and spleen cells
were enriched using a homogenizer. An aliquot of the homogenate
was lysed and plated onto 7H11 agar plates in serial dilutions for
CFU monitoring.
Statistics
Two-tailed Students t test was used to compare the statistical
significance.
Supporting Information
Figure S1 Antibodies to L-type and R-type VGCC bind DCs.
Antibodies to L-type Ca2+ a1C (cat# sc-25686) and R-type Ca2+
a1E (cat # sc-16225) VGCC and NF-kB p65 subunit (cat # sc-
7151) were biotinylated using NHS biotin as per standard
protocols. Cells were washed and counter stained with streptavi-
din-PE. FACS was performed using FACSCalibur (Beckton &
Dickinson) and the data were analyzed employing the CellQuest
Pro software. Histograms depict surface levels of L-type (a & d)
and R-type (b & e) VGCC on CFP10-DCs (a–c) and GM-CSF-
DCs (d–f). Histograms (c & f) depict binding of anti-NF-kB p65
(used as non-specific control). The thin lines depict staining with
streptavidin-PE, while the thick lines depict staining with specific
antibody. One of three independent experiments is shown.
Found at: doi:10.1371/journal.pone.0005305.s001 (0.10 MB
DOC)
Figure S2 siRNA mediated silencing of L-type and R-type
VGCC. 56106/ml bone marrow precursors were transfected with
60 pmoles of siRNA against L-type and R-type VGCC for 72 h
using the Hiperfect transfection reagent (Qiagen) in OPTIMEM
medium (Invitrogen). 5 h following transfection either CFP-10
(Panel A) or GM-CSF (Panel B) was added and the incubation
continued for 72 h for DC differentiation. Subsequently, RNA was
enriched using TRIZOL reagent and levels of VGCC were
monitored by RT-PCR. C, control untransfected DCs. NS,
DCs transfected with siRNA against- firefly luciferase (used as
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non-specific control). L, DCs transfected with siRNA against L-
type VGCC. R, DCs transfected with siRNA against R-type
VGCC. Lower panel represents b-actin as loading controls.
Found at: doi:10.1371/journal.pone.0005305.s002 (0.09 MB TIF)
Figure S3 Blocking L-type and R-type VGCC in CFP10-DCs
increases calcium upon M. tb whole cell lysate stimulation.
Increase in intracellular calcium levels in CFP10-DCs upon
10 mg/ml M. tb whole cell lysate stimulation measured by live cell
imaging using time-lapse video confocal microscopy is shown. DCs
were stimulated at frame # 15 and data on a total of 90 frames
were collected and analyzed using the Image-Pro AMS6.0
software. The values were normalized to unity in order to
represent all groups in a single graph. CFP10-DCs (Blue), CFP10-
DCs+L-type VGCC blocking (Red), CFP10-DCs+R-type VGCC
blocking (Green). Data are representative of three independent
experiments.
Found at: doi:10.1371/journal.pone.0005305.s003 (0.10 MB TIF)
Figure S4 Inhibiting PLCc inhibits calcium induction following
blocking of VGCC. Real time increase in calcium influx over
5 min in CFP10-DCs stimulated with 1 MOI BCG. Prior to
stimulation, DCs were incubated with specific PLCc inhibitor
U73122 for 30 min followed by incubation with antibodies to L-
type and R-type antibody. Panel a, CFP10-DCs treated with
U73122, panel b and c, U73122 treated CFP10-DCs incubated
with anti-L-type and anti-R-type antibodies, respectively.
Found at: doi:10.1371/journal.pone.0005305.s004 (0.07 MB TIF)
Figure S5 Blocking L-type and R-type VGCC induces increased
activation of NF-kB. A, GM-CSF-DCs or CFP10-DCs were
infected with 1 MOI BCG for indicated times. EMSA for NF-kB
was carried out with 10–14 mg of nuclear extracts. Arrow points to
the specific band. GM-CSF-DCs (B) or CFP10-DCs (C) DCs were
incubated with blocking antibody to L-type or R-type VGCC
prior to infection with BCG. Data are representative of three to
five independent experiments.
Found at: doi:10.1371/journal.pone.0005305.s005 (0.13 MB TIF)
Figure S6 Inhibiting L-type and R-type VGCC using siRNA in
macrophages and PBMCs kills intracellular M. tb. Mouse
macrophages (Mph) (upper panel) or human PBMCs (lower
panel) were transfected with siRNAs against L-type and R-type
followed by infection with M. tb H37Rv. 48 h post-infection cell
lysates were plated for CFU monitoring. IFN-g, cells incubated
with 2 ng/ml IFN-c prior to infection with M. tb H37Rv. Data
are the mean of two independent experiments. Error bars
represent mean6s.d. For macrophages P,0.007 for Mph vs
Mph+anti-Ltype+anti-Rtype. P,0.01 for PBMCs vs
PBMCs+anti-Ltype+anti-Rtype, P,0.03 for PBMCs+IFN-g vs
PBMCs+anti-Ltype+anti-Rtype. Two-tailed Student’s t-test was
employed for P values.
Found at: doi:10.1371/journal.pone.0005305.s006 (0.07 MB TIF)
Figure S7 Blocking L-type and R-type VGCC in M. tb infected
macrophages induces caspase 3 activation. Western blots of
cleaved and total caspase 3 levels in mouse peritoneal macro-
phages infected with 1 MOI M. tb H37Rv for 24 h. In some
groups L-type and R-type VGCC were blocked with antibody and
the incubation continued for 24 h. Data are representative of two
independent experiments.
Found at: doi:10.1371/journal.pone.0005305.s007 (0.06 MB TIF)
Movie S1 CFP10-DCs induce weak calcium influx. CFP10-DCs
were loaded with FLUO-3-AM. Following acquisition of 15
frames as baseline, DCs were stimulated with 10 mg/ml M. tb
whole cell lysate. A total of 90 frames were recorded. The movie
depicts frames # 7–55. Each scanning frame has been taken at an
interval of 2 seconds.
Found at: doi:10.1371/journal.pone.0005305.s008 (9.64 MB AVI)
Movie S2 Blocking L-type VGCC in CFP10-DCs induces strong
influx of calcium. CFP10-DCs were incubated with antibody to L-
type VGCC and subsequently loaded with FLUO-3-AM.
Following acquisition of 15 frames as baseline, DCs were
stimulated with 10 mg/ml M. tb whole cell lysate. A total of 90
frames were recorded. The movie depicts frames # 7–55. Each
scanning frame has been taken at an interval of 2 seconds.
Found at: doi:10.1371/journal.pone.0005305.s009 (9.64 MB AVI)
Movie S3 Blocking R-type VGCC in CFP10-DCs induces
strong influx of calcium. CFP10-DCs were incubated with
antibody to R-type VGCC and subsequently loaded with
FLUO-3-AM. Following acquisition of 15 frames as baseline,
DCs were stimulated with 10 mg/ml M. tb whole cell lysate. A
total of 90 frames were recorded. The movie depicts frames # 7–
55. Each scanning frame has been taken at an interval of
2 seconds.
Found at: doi:10.1371/journal.pone.0005305.s010 (9.64 MB AVI)
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